| Pacific Fertility Center Los Angeles (PFCLA) | 91.7 | 3 | 3 |
| Texas Fertility Center | 83.4 | 3 | 2 |
| Prelude Fertility | 83.4 | 3 | 2 |
| Pacific Fertility Center | 71.7 | 3 | 1 |
| Fertility Center of San Antonio | 61.0 | 2 | 1 |
| San Diego Fertility Center | 61.0 | 2 | 1 |
| Fertility Center of Las Vegas | 61.0 | 2 | 1 |
| Colorado Center for Reproductive Medicine | 61.0 | 2 | 1 |
| Shady Grove Fertility Center | 61.0 | 2 | 1 |
| Sher Fertility | 61.0 | 2 | 1 |
| Fertility Centers of Illinois | 61.0 | 2 | 1 |
| New Hope Fertility Center | 61.0 | 2 | 1 |
| Mayo Clinic | 60.0 | 4 | 0 |
| National Institute for Occupational Safety and Health | 51.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 51.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 51.7 | 3 | 0 |
| Office of Readiness and Response | 51.7 | 3 | 0 |
| American Society for Reproductive Medicine | 45.8 | 1 | 1 |
| Seattle Reproductive Medicine | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New York | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 45.8 | 1 | 1 |
| Obi Health | 45.8 | 1 | 1 |
| Epi Info | 41.0 | 2 | 0 |
| Rusk Institute of Rehabilitation Medicine | 41.0 | 2 | 0 |
| Preventing Chronic Disease | 41.0 | 2 | 0 |
| National Survey of Family Growth | 41.0 | 2 | 0 |
| National Vital Statistics System | 41.0 | 2 | 0 |
| NIOSH Power Tools Database | 41.0 | 2 | 0 |
| Oregon Graduate Center | 41.0 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 41.0 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 41.0 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 41.0 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 41.0 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 41.0 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 41.0 | 2 | 0 |
| NCHS data brief | 41.0 | 2 | 0 |
| MMWR supplements | 41.0 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 41.0 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 41.0 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 41.0 | 2 | 0 |
| Cooper Health System | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| Christopher R. Conley | 41.0 | 2 | 0 |
| Healthcare Infection Control Practices Advisory Committee | 41.0 | 2 | 0 |
| Suenos de un Pueblo: Dreams of the People. An Oral History of the Crewport Farm Labor Camp | 41.0 | 2 | 0 |
| Progyny, Inc. | 41.0 | 2 | 0 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 41.0 | 2 | 0 |
| assisted reproductive technology | 40.0 | 0 | 3 |
| fertility clinic | 40.0 | 0 | 3 |
| Fertility and Sterility | 40.0 | 0 | 3 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 40.0 | 0 | 3 |
| Elective single-embryo transfer | 40.0 | 0 | 3 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 40.0 | 0 | 3 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 40.0 | 0 | 3 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 40.0 | 0 | 3 |
| fertility tourism | 31.7 | 0 | 2 |
| Reproductive Medicine and Biology | 31.7 | 0 | 2 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 31.7 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 31.7 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 31.7 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 31.7 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 31.7 | 0 | 2 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 31.7 | 0 | 2 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 31.7 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 31.7 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 31.7 | 0 | 2 |
| Pregnancy outcomes after assisted reproductive technology | 31.7 | 0 | 2 |
| Fertility clinic, egg donation agency, and sperm bank policies | 31.7 | 0 | 2 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 31.7 | 0 | 2 |
| The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry | 31.7 | 0 | 2 |
| The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer | 31.7 | 0 | 2 |
| Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database | 31.7 | 0 | 2 |
| Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 31.7 | 0 | 2 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention | 31.7 | 0 | 2 |
| Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study | 31.7 | 0 | 2 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI). | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 31.7 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 31.7 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 31.7 | 0 | 2 |
| Optimizing natural fertility | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut | 31.7 | 0 | 2 |
| Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches | 31.7 | 0 | 2 |
| Validation of infertility treatment and assisted reproductive technology use on the birth certificate in eight states | 31.7 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion | 31.7 | 0 | 2 |
| Multiple gestations/pregnancies from IVF process in a fertility center in Nigeria, 2009-2011: implementing policy towards fewer (double and single) embryo transfer | 31.7 | 0 | 2 |
| In vitro maturation: a committee opinion | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 31.7 | 0 | 2 |
| VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications | 31.7 | 0 | 2 |
| Role of assisted hatching in in vitro fertilization: a guideline | 31.7 | 0 | 2 |
| Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion | 31.7 | 0 | 2 |
| Assisted reproductive technology - IVF treatment in Ireland: A study of couples with successful outcomes | 31.7 | 0 | 2 |
| Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review | 31.7 | 0 | 2 |
| Role of tubal surgery in the era of assisted reproductive technology: a committee opinion | 31.7 | 0 | 2 |
| Role of the mental health professional in education and support of the medical staff | 31.7 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 31.7 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites | 31.7 | 0 | 2 |
| Factors predicting double embryo implantation following double embryo transfer in assisted reproductive technology: implications for elective single embryo transfer | 31.7 | 0 | 2 |
| Guidance on the limits to the number of embryos to transfer: a committee opinion | 31.7 | 0 | 2 |
| Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology | 31.7 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 31.7 | 0 | 2 |
| Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey | 31.7 | 0 | 2 |
| Performing the embryo transfer: a guideline | 31.7 | 0 | 2 |
| Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia | 31.7 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 31.7 | 0 | 2 |
| Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle | 31.7 | 0 | 2 |
| Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Position statement on West Nile virus: a committee opinion | 31.7 | 0 | 2 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 31.7 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus | 31.7 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus | 31.7 | 0 | 2 |
| American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile Virus | 31.7 | 0 | 2 |
| Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study | 31.7 | 0 | 2 |
| The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer | 31.7 | 0 | 2 |
| Position on reproductive donors and smallpox vaccine: a committee opinion | 31.7 | 0 | 2 |
| Hormonal and Clinical Predictors for Post-egg Retrieval Pain in Women Undergoing Assisted Reproductive Technology Procedures. | 31.7 | 0 | 2 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 31.7 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 31.7 | 0 | 2 |
| Safety in reproductive medicine: breadth, depth and discovery | 31.7 | 0 | 2 |
| Mature oocyte cryopreservation: a guideline | 31.7 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 31.7 | 0 | 2 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 31.7 | 0 | 2 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 31.7 | 0 | 2 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 31.7 | 0 | 2 |
| Fertility Treatments in the United States: Improving Access and Outcomes | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| Estimation of the Contribution of Assisted and Non-Assisted Reproductive Technology Fertility Treatments to Multiple Births During the Past 30 Years in Japan: 1979–2008 | 31.7 | 0 | 2 |
| Perinatal outcomes after assisted reproductive technology treatment in Australia and New Zealand: single versus double embryo transfer. | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 31.7 | 0 | 2 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 31.7 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 31.7 | 0 | 2 |
| Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial | 31.7 | 0 | 2 |
| Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 31.7 | 0 | 2 |
| Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 31.7 | 0 | 2 |
| Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus). | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Guidelines on number of embryos transferred | 31.7 | 0 | 2 |
| Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin | 31.7 | 0 | 2 |
| Trends and factors associated with the Day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001-2009. | 31.7 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 31.7 | 0 | 2 |
| Embryo transfer practices in the United States: a survey of clinics registered with the Society for Assisted Reproductive Technology | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| Treatment period and medical care costs to achieve the first live birth by assisted reproductive technology are lower in the single embryo transfer period than in the double embryo transfer period: a retrospective analysis of women younger than 40 y | 31.7 | 0 | 2 |
| Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society for Assisted Reproductive Technology | 31.7 | 0 | 2 |
| Stimulation of endometrium embryo transfer can improve implantation and pregnancy rates for patients undergoing assisted reproductive technology for the first time with a high-grade blastocyst | 31.7 | 0 | 2 |
| Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran | 31.7 | 0 | 2 |
| Association Between Pesticide Residue Intake From Consumption of Fruits and Vegetables and Pregnancy Outcomes Among Women Undergoing Infertility Treatment With Assisted Reproductive Technology | 31.7 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Assisted reproductive technology in reproductive medicine - possibilities and limitations | 31.7 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 31.7 | 0 | 2 |
| Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise | 31.7 | 0 | 2 |
| Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013. | 31.7 | 0 | 2 |
| Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort | 31.7 | 0 | 2 |
| Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH-agonist protocol IVF cycle | 31.7 | 0 | 2 |
| There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy | 31.7 | 0 | 2 |
| American Society for Reproductive Medicine Updates Consent Forms for Egg Donation | 31.7 | 0 | 2 |
| Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection | 31.7 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion | 31.7 | 0 | 2 |
| Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology | 31.7 | 0 | 2 |
| What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics? | 31.7 | 0 | 2 |
| Recommendations for gamete and embryo donation: a committee opinion | 31.7 | 0 | 2 |
| 2008 Guidelines for gamete and embryo donation: a Practice Committee report | 31.7 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 31.7 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies | 31.7 | 0 | 2 |
| Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion | 31.7 | 0 | 2 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 31.7 | 0 | 2 |
| Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births | 31.7 | 0 | 2 |
| Ethical issues of egg donation | 31.7 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 31.7 | 0 | 2 |
| IVF Centers Prof. Zech | 31.7 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 31.7 | 0 | 2 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 31.7 | 0 | 2 |
| Assisted reproductive technology : strategies of elective single embryo transfer | 31.7 | 0 | 2 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 31.7 | 0 | 2 |
| 1995 assisted reproductive technology success rates: national summary and fertility clinic report. | 31.7 | 0 | 2 |
| 2006 Guidelines for Gamete and Embryo Donation | 31.7 | 0 | 2 |
| Elements to be considered in obtaining informed consent for ART. | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Reproductive medicine in transition: new developments in embryo transfer | 31.7 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 31.7 | 0 | 2 |
| Revised guidelines for human embryology and andrology laboratories | 31.7 | 0 | 2 |
| AIDA for reproductive medicine and the fertility clinic | 31.7 | 0 | 2 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 31.7 | 0 | 2 |
| Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic triplets | 31.7 | 0 | 2 |
| Estrous cycle staging before mating led to increased efficiency in the production of pseudopregnant recipients without negatively affecting embryo transfer in mice | 31.7 | 0 | 2 |
| Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments | 31.7 | 0 | 2 |
| AIUM practice guideline for ultrasonography in reproductive medicine | 31.7 | 0 | 2 |
| Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments | 31.7 | 0 | 2 |
| Distributive justice and the regulation of fertility centers: an analysis of the Fertility Clinic Success Rate and Certification Act. | 31.7 | 0 | 2 |
| Recommendations for practices utilizing gestational carriers: a committee opinion | 31.7 | 0 | 2 |
| Comparison of the effect of immediate versus delayed transfer following a stimulated IVF cycle on the ongoing pregnancy rate of frozen-thawed embryo transfer cycles: a study protocol for a randomised controlled trial. | 31.7 | 0 | 2 |
| Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE† | 31.7 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 31.7 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 31.7 | 0 | 2 |
| Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Position statement on West Nile virus: a committee opinion | 31.7 | 0 | 2 |
| Egg donation model: an excellent way to isolate and analyze the impact of the male partner on assisted reproductive technology outcome | 31.7 | 0 | 2 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 31.7 | 0 | 2 |
| THE OPTIMAL INTERVAL OF TIME FROM OPERATIVE HYSTEROSCOPY TO EMBRYO TRANSFER IN AN IVF CYCLE | 31.7 | 0 | 2 |
| Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion | 31.7 | 0 | 2 |
| The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa | 31.7 | 0 | 2 |
| Large for gestational age and macrosomia in singletons born after frozen/thawed embryo transfer (FET) in assisted reproductive technology (ART) | 31.7 | 0 | 2 |
| Health in Childhood Following Assisted Reproductive Technology | 31.7 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 31.7 | 0 | 2 |
| Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 31.7 | 0 | 2 |
| Efficacy of Hypnosis During Embryo Transfer Procedure on Clinical Pregnancy Rate for Patients Undergoing Assisted Reproductive Technology IVF or ICSI | 31.7 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Electro-acupuncture and Assisted Reproductive Technology | 31.7 | 0 | 2 |
| Bed Rest or no Bed Rest? | 31.7 | 0 | 2 |
| Telemedicine Consultation in Trauma and Orthopedic | 31.7 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 31.7 | 0 | 2 |
| Embryotransfer Operator and Pregnancy Rate | 31.7 | 0 | 2 |
| Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool. | 31.7 | 0 | 2 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | 31.7 | 0 | 2 |
| Immediate Versus Delayed FET Following a Stimulated IVF Cycle | 31.7 | 0 | 2 |
| Newborns From Patients Treated With ART (Assisted Reproductive Technology) | 31.7 | 0 | 2 |
| The Use of an Online Learning and Consent Platform in Infertility Treatment | 31.7 | 0 | 2 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 31.7 | 0 | 2 |
| Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound | 31.7 | 0 | 2 |
| Study Comparing Outcomes Between Conventional IVF and a "Freeze-all"-Strategy in Assisted Reproductive Technology | 31.7 | 0 | 2 |
| In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology (SART), The American Fertility Society | 31.7 | 0 | 2 |
| In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET Registry. Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society | 31.7 | 0 | 2 |
| In vitro fertilization-embryo transfer in the United States: 1988 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology. American Fertility Society | 31.7 | 0 | 2 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI) | 31.7 | 0 | 2 |
| Assisted Reproductive Technology in the United States and Canada: 1995 Results Generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments | 31.7 | 0 | 2 |
| Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry | 31.7 | 0 | 2 |
| Infertility treatment and informed consent: current practices of reproductive endocrinologists | 31.7 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion | 31.7 | 0 | 2 |
| Ovarian tissue and oocyte cryopreservation | 31.7 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Preimplantation genetic diagnosis | 31.7 | 0 | 2 |
| Guidelines on number of embryos transferred | 31.7 | 0 | 2 |
| Revised guidelines for human embryology and andrology laboratories | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies | 31.7 | 0 | 2 |
| Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer | 31.7 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States | 31.7 | 0 | 2 |
| The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation | 31.7 | 0 | 2 |
| Guidelines for advertising by ART programs | 31.7 | 0 | 2 |
| Guidelines on the number of embryos transferred | 31.7 | 0 | 2 |
| Guidelines for advertising by ART programs | 31.7 | 0 | 2 |
| Revised minimum standards for practices offering assisted reproductive technologies | 31.7 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI) | 31.7 | 0 | 2 |
| Embryo splitting for infertility treatment | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 31.7 | 0 | 2 |
| Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility | 31.7 | 0 | 2 |
| Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility: depth of the problem and possible solutions | 31.7 | 0 | 2 |
| Single embryo transfer in IVF treatment | 31.7 | 0 | 2 |
| Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology | 31.7 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI) | 31.7 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion | 31.7 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Ovarian tissue and oocyte cryopreservation | 31.7 | 0 | 2 |
| Revised guidelines for human embryology and andrology laboratories | 31.7 | 0 | 2 |
| Acupuncture intervention combined with assisted reproductive technology: its different effects at different time points during the in vitro fertilization-embryo transfer course | 31.7 | 0 | 2 |
| Committee opinion: role of tubal surgery in the era of assisted reproductive technology | 31.7 | 0 | 2 |
| Practice patterns and outcomes with the use of single embryo transfer in the United States | 31.7 | 0 | 2 |
| Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee guideline | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: a committee opinion | 31.7 | 0 | 2 |
| Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? | 31.7 | 0 | 2 |
| Position statement on West Nile virus: a committee opinion | 31.7 | 0 | 2 |
| Correct coding for laboratory procedures during assisted reproductive technology cycles | 31.7 | 0 | 2 |
| Guidelines on number of embryos transferred | 31.7 | 0 | 2 |
| Re: "Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births" | 31.7 | 0 | 2 |
| Criteria for number of embryos to transfer: a committee opinion | 31.7 | 0 | 2 |
| AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan | 31.7 | 0 | 2 |
| [Modalities of acupuncture treatments in assisted reproductive technology--a comparison of treatment practice in Swiss, German, and Austrian fertility centers with findings from randomized controlled trials] | 31.7 | 0 | 2 |
| Psychosocial factors in reproductive medicine | 31.7 | 0 | 2 |
| Use of reproductive technology for sex selection for nonmedical reasons | 31.7 | 0 | 2 |
| [Assisted Reproductive Technology in Female Transplant Recipients: Experience of a Reproductive Medicine Unit and Literature Review] | 31.7 | 0 | 2 |
| Validity for assisted hatching on pregnancy rate in assisted reproductive technology: Analysis based on results of Japan Assisted Reproductive Technology Registry System 2010 | 31.7 | 0 | 2 |
| The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion | 31.7 | 0 | 2 |
| ASRM standard embryo transfer protocol template: a committee opinion | 31.7 | 0 | 2 |
| Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes | 31.7 | 0 | 2 |
| Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion | 31.7 | 0 | 2 |
| Reporting assisted reproductive technology success rates on Australian and New Zealand fertility clinic websites | 31.7 | 0 | 2 |
| The effect of fresh IVF cycle characteristics on frozen embryo transfer (FET) outcomes | 31.7 | 0 | 2 |
| Minimum standards for practices offering assisted reproductive technologies: a committee opinion | 31.7 | 0 | 2 |
| Assisted Reproductive Technology and the Reproductive Endocrinology and Infertility Specialist in the U.S. Military | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Re: Assisted Reproductive Technology Outcomes in Female-to-Male Transgender Patients Compared with Cisgender Patients: A New Frontier in Reproductive Medicine | 31.7 | 0 | 2 |
| Herbal fertility treatments used in North America from colonial times to 1900, and their potential for improving the success rate of assisted reproductive technology | 31.7 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 31.7 | 0 | 2 |
| Androgenicity and fertility treatment in women with unexplained infertility | 31.7 | 0 | 2 |
| Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine | 31.7 | 0 | 2 |
| Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 31.7 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 31.7 | 0 | 2 |
| Influence of surgical evacuation on pregnancy outcomes of subsequent embryo transfer cycle following miscarriage in an initial IVF cycle: a retrospective cohort study | 31.7 | 0 | 2 |
| Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology | 31.7 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 31.7 | 0 | 2 |
| A counterintuitive lesson in family planning? Patience first: taking a "gap year" after live birth from assisted reproductive technology before frozen embryo transfer is performed | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion | 31.7 | 0 | 2 |
| A Chinese practice guideline of the assisted reproductive technology strategies for women with advanced age | 31.7 | 0 | 2 |
| Re: Egg Donation Model: An Excellent Way to Isolate and Analyze the Impact of the Male Partner on Assisted Reproductive Technology Outcome | 31.7 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 31.7 | 0 | 2 |
| Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum | 31.7 | 0 | 2 |
| A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed Frozen Embryo Transfer (FET) Following a Freeze-all Strategy | 31.7 | 0 | 2 |
| College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories | 31.7 | 0 | 2 |
| Guidelines on the number of embryos transferred | 31.7 | 0 | 2 |
| Virtual Reality Use in Assisted Reproductive Technology | 31.7 | 0 | 2 |
| [Preparation for assisted reproductive technology in the course of infertility treatment in the female soldiers] | 31.7 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 31.7 | 0 | 2 |
| Use of Remote Monitoring for COVID-19 Patient | 31.7 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 31.7 | 0 | 2 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion | 31.7 | 0 | 2 |
| Cryostorage of reproductive tissues in the in vitro fertilization laboratory: a committee opinion | 31.7 | 0 | 2 |
| The Effect of Male Sexual Abstinence Periods on the Clinical Outcomes of Fresh Embryo Transfer Cycles Following Assisted Reproductive Technology: A Meta-Analysis | 31.7 | 0 | 2 |
| IVM Survey Among Reproductive Medicine Specialists | 31.7 | 0 | 2 |
| Ng Soon Chye | 31.7 | 0 | 2 |
| Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study | 31.7 | 0 | 2 |
| Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center | 31.7 | 0 | 2 |
| Fertility clinic advertising in the United States: is the Society for Assisted Reproductive Technology oversight of advertising policy effective? | 31.7 | 0 | 2 |
| Effect of the Interaction Between Pre-pregnancy Body Mass Index and Fresh/Frozen Embryo Transfer on Perinatal Outcomes of Assisted Reproductive Technology-Conceived Singletons: A Retrospective Cohort Study | 31.7 | 0 | 2 |
| Effects of waiting time between failed fresh cycle embryo transfer and the next frozen embryo transfer on pregnancy outcomes in assisted reproductive technology | 31.7 | 0 | 2 |
| Risk factors for resignation from work after starting infertility treatment among Japanese women: Japan-Female Employment and Mental health in Assisted reproductive technology (J-FEMA) study | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites | 31.7 | 0 | 2 |
| Outcome of mock embryo transfer before the first IVF cycle: A randomized control trial | 31.7 | 0 | 2 |
| Simulation training for embryo transfer: findings from the American Society for Reproductive Medicine Embryo Transfer Certificate Course | 31.7 | 0 | 2 |
| In vitro maturation: a committee opinion | 31.7 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 31.7 | 0 | 2 |
| “Add-Ons” for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics’ Websites? | 31.7 | 0 | 2 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 31.7 | 0 | 2 |
| MentorApp for Cancer Patient's Remote Monitoring | 31.7 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 31.7 | 0 | 2 |
| Perinatal Outcome Following Assisted Reproductive Technology Treatment at A Tertiary Fertility Center In Nepal | 31.7 | 0 | 2 |
| KINDERWUNSCHZENTRUM LOS ANGELES, INC. | 31.7 | 0 | 2 |
| Pregnancy Rate (PR) With In-Vitro Fertilization (IVF) When the Egg Retrieval (ER) and the Embryo Transfer (ET) are Done by the Same Physician or by Different Physicians | 31.7 | 0 | 2 |
| Fertility-sparing treatment (FST) and assisted reproductive technology (ART) in patients with endometrial carcinoma (EMCA) and endometrial intraepithelial neoplasia (EIN): pregnancy outcomes after embryo transfer (ET) | 31.7 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 31.7 | 0 | 2 |
| Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology | 31.7 | 0 | 2 |
| Hyaluronic acid-enriched embryo transfer medium in assisted reproductive technology programs: mechanism of action and indications for use | 31.7 | 0 | 2 |
| Efficacy of intrauterine administration of autologous peripheral blood mononuclear cells prior to embryo transfer in patients with recurrent implantation failures in assisted reproductive technology programmes | 31.7 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 31.7 | 0 | 2 |
| Embryo biopsy does not affect the rate of multiples after single embryo transfer (SET): a review of the society for assisted reproductive technology (SART) reported outcomes | 31.7 | 0 | 2 |
| Effect of transcervical embryo transfer on placental location in patients undergoing assisted reproductive technology | 31.7 | 0 | 2 |
| For women undergoing assisted reproductive technology (ART) procedures, does hyaluronic acid used as an adherence compound during embryo transfer improve outcomes? | 31.7 | 0 | 2 |
| The Implications of Double Human Chorionic Gonadotropin (hCG) Trigger on a Pseudo-Empty Follicle Syndrome Patient Seeking Infertility Treatment Through Assisted Reproductive Technology (ART) | 31.7 | 0 | 2 |
| Can adding seminal plasma to the female genital tract before embryo transfer improve outcomes for couples undergoing assisted reproductive technology (ART)? | 31.7 | 0 | 2 |
| The gift of motherhood: Egg donation in a Barcelona infertility clinic | 31.7 | 0 | 2 |
| Q137356371 | 31.7 | 0 | 2 |
| Cryopreserving Jewish Motherhood: Egg Freezing in Israel and the United States | 31.7 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 31.7 | 0 | 2 |
| From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain | 31.7 | 0 | 2 |
| Genera PMA | 31.7 | 0 | 2 |
| Genesis Fertility Center | 31.7 | 0 | 2 |
| GYN-FIV a.s. | 31.7 | 0 | 2 |
| Q229883 | 25.8 | 1 | 0 |
| Oregon Health and Science University | 25.8 | 1 | 0 |
| United States Centers for Disease Control and Prevention | 25.8 | 1 | 0 |
| Cystic Fibrosis Foundation | 25.8 | 1 | 0 |
| Johns Hopkins School of Medicine | 25.8 | 1 | 0 |
| University of California, San Francisco | 25.8 | 1 | 0 |
| Johns Hopkins Hospital | 25.8 | 1 | 0 |
| Mount Sinai Hospital | 25.8 | 1 | 0 |
| polymyalgia rheumatica | 25.8 | 1 | 0 |
| Morbidity and Mortality Weekly Report | 25.8 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 25.8 | 1 | 0 |
| Brigham and Women's Hospital | 25.8 | 1 | 0 |
| Grossman School of Medicine | 25.8 | 1 | 0 |
| National Center for Health Statistics | 25.8 | 1 | 0 |
| Weill Cornell Medicine | 25.8 | 1 | 0 |
| Advisory Committee on Immunization Practices | 25.8 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 25.8 | 1 | 0 |
| Anne Schuchat | 25.8 | 1 | 0 |
| Arthur L. Jenkins | 25.8 | 1 | 0 |
| Community Memorial Hospital | 25.8 | 1 | 0 |
| Cooper University Hospital | 25.8 | 1 | 0 |
| Corinne Goldsmith Dickinson Center for Multiple Sclerosis | 25.8 | 1 | 0 |
| Emerging Infectious Diseases | 25.8 | 1 | 0 |
| Enid A. Haupt Glass Garden | 25.8 | 1 | 0 |
| Epi Map | 25.8 | 1 | 0 |
| Epidemic Intelligence Service | 25.8 | 1 | 0 |
| Fire Fighter Fatality Investigation and Prevention Program | 25.8 | 1 | 0 |
| Froedtert Hospital | 25.8 | 1 | 0 |
| Genetics and IVF Institute | 25.8 | 1 | 0 |
| Health Hazard Evaluation | 25.8 | 1 | 0 |
| Howard County General Hospital | 25.8 | 1 | 0 |
| Mayo Clinic Hospital – Jacksonville | 25.8 | 1 | 0 |
| Mayo School of Health Sciences | 25.8 | 1 | 0 |
| McGuireWoods | 25.8 | 1 | 0 |
| NYU Langone Health | 25.8 | 1 | 0 |
| National Center for Injury Prevention and Control | 25.8 | 1 | 0 |
| National Diabetes Education Program | 25.8 | 1 | 0 |
| National Health Interview Survey | 25.8 | 1 | 0 |
| Oregon Health & Science University School of Dentistry | 25.8 | 1 | 0 |
| Oregon Health & Science University Hospital | 25.8 | 1 | 0 |
| Public Health Information Network | 25.8 | 1 | 0 |
| Sanford Health | 25.8 | 1 | 0 |
| Sanford USD Medical Center | 25.8 | 1 | 0 |
| Sibley Memorial Hospital | 25.8 | 1 | 0 |
| Sofia Frangou | 25.8 | 1 | 0 |
| Stanford Hospital and Clinics | 25.8 | 1 | 0 |
| Stanford University Medical Center | 25.8 | 1 | 0 |
| UCSF Medical Center | 25.8 | 1 | 0 |
| VERB | 25.8 | 1 | 0 |
| Vaccines for Children Program | 25.8 | 1 | 0 |
| Victor Velculescu | 25.8 | 1 | 0 |
| NIOSH World Trade Center Health Program | 25.8 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 25.8 | 1 | 0 |
| Theodore H. Schwartz | 25.8 | 1 | 0 |
| Q16117390 | 25.8 | 1 | 0 |
| National Death Index | 25.8 | 1 | 0 |
| National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention | 25.8 | 1 | 0 |
| Suburban Hospital | 25.8 | 1 | 0 |
| National Center for Immunization and Respiratory Diseases | 25.8 | 1 | 0 |
| Vollum Institute | 25.8 | 1 | 0 |
| Oregon Health and Science University Center for Women's Health | 25.8 | 1 | 0 |
| NIOSH pocket guide to chemical hazards (superseded) | 25.8 | 1 | 0 |
| William G. Nelson | 25.8 | 1 | 0 |
| Charles Limb | 25.8 | 1 | 0 |
| National Violent Death Reporting System | 25.8 | 1 | 0 |
| Sonja A. Rasmussen | 25.8 | 1 | 0 |
| Adriana Di Martino | 25.8 | 1 | 0 |
| Anne Marie Clare Kelly | 25.8 | 1 | 0 |
| Mayo Clinic Graduate School of Biomedical Sciences | 25.8 | 1 | 0 |
| Monthly vital statistics report : provisional statistics from the National Center for Health Statistics | 25.8 | 1 | 0 |
| John J. Sidtis | 25.8 | 1 | 0 |
| Advance data | 25.8 | 1 | 0 |
| Vital and health statistics. Series 10, Data from the National Health Survey | 25.8 | 1 | 0 |
| Vital and health statistics. Series 11, Data from the national health survey | 25.8 | 1 | 0 |
| Vital and health statistics. Series 21, Data from the National Vital Statistics System | 25.8 | 1 | 0 |
| Vital and health statistics. Series 23, Data from the National Survey of Family Growth | 25.8 | 1 | 0 |
| Vital and health statistics. Series 20, Data from the National Vital Statistics System | 25.8 | 1 | 0 |
| National health statistics reports | 25.8 | 1 | 0 |
| Eric Gouaux | 25.8 | 1 | 0 |
| Sidney Kimmel Comprehensive Cancer Center | 25.8 | 1 | 0 |
| Office of Public Health Genomics | 25.8 | 1 | 0 |
| Alejandro Aballay | 25.8 | 1 | 0 |
| NYU Langone Orthopedic Hospital | 25.8 | 1 | 0 |
| Office of Public Health Preparedness and Response | 25.8 | 1 | 0 |
| Office for State, Tribal, Local and Territorial Support | 25.8 | 1 | 0 |
| Center for Global Health | 25.8 | 1 | 0 |
| Mayo Clinic Hospital | 25.8 | 1 | 0 |
| San Juan Quarantine Station | 25.8 | 1 | 0 |
| Oregon Health & Science University School of Medicine | 25.8 | 1 | 0 |
| Barcelona IVI Clinic | 25.8 | 1 | 0 |
| IVI Madrid Clinic | 25.8 | 1 | 0 |
| IVI Sevilla Clinic | 25.8 | 1 | 0 |
| IVI Valencia Clinic | 25.8 | 1 | 0 |
| Instituto Bernabeu | 25.8 | 1 | 0 |
| Boston IVF | 25.8 | 1 | 0 |
| Igenomix | 25.8 | 1 | 0 |
| Sanford Heart Hospital | 25.8 | 1 | 0 |
| Reproductive Science Center | 25.8 | 1 | 0 |
| National Center for Environmental Health | 25.8 | 1 | 0 |
| Center for Human Reproduction | 25.8 | 1 | 0 |
| Reproductive Genetics Institute | 25.8 | 1 | 0 |
| National Center for Infectious Diseases | 25.8 | 1 | 0 |
| Valencian Infertility Institute | 25.8 | 1 | 0 |
| Sanford Children's Specialty Clinic | 25.8 | 1 | 0 |
| National Center on Birth Defects and Developmental Disabilities | 25.8 | 1 | 0 |
| Division of Regulatory Science and Compliance | 25.8 | 1 | 0 |
| Gira Bhabha | 25.8 | 1 | 0 |
| Office of Infectious Diseases | 25.8 | 1 | 0 |
| Center for Surveillance, Epidemiology, and Laboratory Services | 25.8 | 1 | 0 |
| Office of Minority Health and Health Equity | 25.8 | 1 | 0 |
| Mayo Clinic Scottsdale | 25.8 | 1 | 0 |
| Systems Biology in Reproductive Medicine | 20.0 | 0 | 1 |
| Robert Edwards | 20.0 | 0 | 1 |
| in vitro fertilization | 20.0 | 0 | 1 |
| Gigi Fernández | 20.0 | 0 | 1 |
| embryo transfer | 20.0 | 0 | 1 |
| reproductive medicine | 20.0 | 0 | 1 |
| Kitakyushu Airport | 20.0 | 0 | 1 |
| Sky Gate Bridge R | 20.0 | 0 | 1 |
| Sendai Airport Line | 20.0 | 0 | 1 |
| egg donation | 20.0 | 0 | 1 |
| telecontrol | 20.0 | 0 | 1 |
| GE's Automation & Controls | 20.0 | 0 | 1 |
| contingency plan | 20.0 | 0 | 1 |
| tracking | 20.0 | 0 | 1 |
| Creighton Model FertilityCare System | 20.0 | 0 | 1 |
| telemonitoring | 20.0 | 0 | 1 |
| Vitrification (ovocytes) | 20.0 | 0 | 1 |
| Taoyuan Airport MRT | 20.0 | 0 | 1 |
| Assisted zona hatching | 20.0 | 0 | 1 |
| Autologous endometrial coculture | 20.0 | 0 | 1 |
| telehealth | 20.0 | 0 | 1 |
| Cable Liner | 20.0 | 0 | 1 |
| Center for Reproductive Medicine | 20.0 | 0 | 1 |
| Endocrinology of reproduction | 20.0 | 0 | 1 |
| Ericsson method | 20.0 | 0 | 1 |
| CHARME | 20.0 | 0 | 1 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 20.0 | 0 | 1 |
| Template:Assisted reproductive technology | 20.0 | 0 | 1 |
| patient portal | 20.0 | 0 | 1 |
| religious response to assisted reproductive technology | 20.0 | 0 | 1 |
| Remote monitoring and control | 20.0 | 0 | 1 |
| remote patient monitoring | 20.0 | 0 | 1 |
| Reproductive endocrinology | 20.0 | 0 | 1 |
| reproductive surgery | 20.0 | 0 | 1 |
| Sahar Elevated Access Road | 20.0 | 0 | 1 |
| semen collection | 20.0 | 0 | 1 |
| Slovenian fertility treatment referendum, 2001 | 20.0 | 0 | 1 |
| Category:A-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Assisted reproductive technology | 20.0 | 0 | 1 |
| Category:B-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:C-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:FA-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:FL-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:GA-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:High-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Low-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Mid-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Reproductive medicine articles by importance | 20.0 | 0 | 1 |
| Category:Reproductive medicine articles by quality | 20.0 | 0 | 1 |
| Category:Reproductive medicine task force | 20.0 | 0 | 1 |
| Category:Reproductive medicine task force articles | 20.0 | 0 | 1 |
| Category:NA-Class reproductive medicine pages | 20.0 | 0 | 1 |
| Category:NA-importance reproductive medicine pages | 20.0 | 0 | 1 |
| Category:Start-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Stub-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Top-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Unassessed reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Unknown-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Embrapa Territorial | 20.0 | 0 | 1 |
| Airport Terminal 3 Station | 20.0 | 0 | 1 |
| Ibaraki Airport access road | 20.0 | 0 | 1 |
| Fukuoka Prefectural Road Route 245 | 20.0 | 0 | 1 |
| Q12306678 | 20.0 | 0 | 1 |
| Category:List-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Seminars in Reproductive Medicine | 20.0 | 0 | 1 |
| Molecular Human Reproduction | 20.0 | 0 | 1 |
| Journal of Reproductive Medicine | 20.0 | 0 | 1 |
| Obstetrics, Gynaecology and Reproductive Medicine | 20.0 | 0 | 1 |
| Anna Glasier | 20.0 | 0 | 1 |
| Akanksha Infertility Clinic | 20.0 | 0 | 1 |
| medical assistance to procreation in France | 20.0 | 0 | 1 |
| reproductive endocrinology and infertility | 20.0 | 0 | 1 |
| Sendai Airport Access Line | 20.0 | 0 | 1 |
| Coliseum–Oakland International Airport line | 20.0 | 0 | 1 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 20.0 | 0 | 1 |
| Reproductive medicine in northwest Argentina: traditional and institutional systems | 20.0 | 0 | 1 |
| WikiProject Reproductive medicine | 20.0 | 0 | 1 |
| Consensus on infertility treatment related to polycystic ovary syndrome | 20.0 | 0 | 1 |
| Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome | 20.0 | 0 | 1 |
| An historical look at embryo transfer | 20.0 | 0 | 1 |
| Peter C. Klatsky | 20.0 | 0 | 1 |
| Naprotechnology | 20.0 | 0 | 1 |
| Clinical adaptation of the sperm ubiquiting tag immunoassay (SUTI): relationship of sperm ubiquitylation with sperm quality in gradient-purified semen samples from 93 men from a general infertility clinic population | 20.0 | 0 | 1 |
| The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments | 20.0 | 0 | 1 |
| Computerized, remote monitoring systems for underground coal mines. fires and explosive atmospheres | 20.0 | 0 | 1 |
| Gonadotrophin-releasing hormone antagonists for assisted reproductive technology | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Assisted reproductive technology: an overview of Cochrane Reviews | 20.0 | 0 | 1 |
| Assisted reproductive technology: an overview of Cochrane Reviews | 20.0 | 0 | 1 |
| Culture media for human pre-implantation embryos in assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology | 20.0 | 0 | 1 |
| Vasodilators for women undergoing fertility treatment | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 20.0 | 0 | 1 |
| Assisted reproductive technology: an overview of Cochrane Reviews | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Assisted reproductive technology: an overview of Cochrane Reviews | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Acupuncture and assisted reproductive technology | 20.0 | 0 | 1 |
| Peri-implantation glucocorticoid administration for assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Immune therapies for women with history of failed implantation undergoing IVF treatment | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Gonadotrophin-releasing hormone antagonists for assisted reproductive technology | 20.0 | 0 | 1 |
| Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 20.0 | 0 | 1 |
| Interventions for women with endometrioma prior to assisted reproductive technology | 20.0 | 0 | 1 |
| Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Culture media for human preimplantation embryos in assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Nonsteroidal anti-inflammatory drugs for assisted reproductive technology | 20.0 | 0 | 1 |
| Cycle regimens for frozen-thawed embryo transfer | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Peri-implantation glucocorticoid administration for assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Peri-implantation glucocorticoid administration for assisted reproductive technology cycles | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| In memoriam: Celso-Ramon Garcia, M.D. (1922-2004), reproductive medicine visionary | 20.0 | 0 | 1 |
| Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers | 20.0 | 0 | 1 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 20.0 | 0 | 1 |
| Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic | 20.0 | 0 | 1 |
| Radiologic and nuclear events: contingency planning for hematologists/oncologists | 20.0 | 0 | 1 |
| Infertility, infertility treatment, and congenital malformations: Danish national birth cohort | 20.0 | 0 | 1 |
| Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis | 20.0 | 0 | 1 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 20.0 | 0 | 1 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 20.0 | 0 | 1 |
| The stork and the syringe: a political history of reproductive medicine | 20.0 | 0 | 1 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 20.0 | 0 | 1 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 20.0 | 0 | 1 |
| Clarifying the role of three-dimensional transvaginal sonography in reproductive medicine: an evidenced-based appraisal | 20.0 | 0 | 1 |
| Follicular fluid levels of vascular endothelial growth factor and early corpus luteum function during assisted reproductive technology cycles | 20.0 | 0 | 1 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 20.0 | 0 | 1 |
| Haneda Airport Access Line | 20.0 | 0 | 1 |
| remote monitoring and management | 20.0 | 0 | 1 |
| Category:Medicine/Reproductive medicine task force articles needing expert attention | 20.0 | 0 | 1 |
| Remote monitoring of mine seismicity and earthquakes using radio telemetry, computers, and the internet | 20.0 | 0 | 1 |
| Remote monitoring of coal waste embankments | 20.0 | 0 | 1 |
| Computerized, remote monitoring systems for underground coal mines. Faults in power systems | 20.0 | 0 | 1 |
| Satellite monitoring for a coal waste embankment | 20.0 | 0 | 1 |
| Remote monitoring of air quality in underground mines | 20.0 | 0 | 1 |
| Satellite Monitoring of Open Pit Mining Operations | 20.0 | 0 | 1 |
| Remote monitoring of a coal waste impoundment in West Virginia | 20.0 | 0 | 1 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 20.0 | 0 | 1 |
| A Review of The Society for Assisted Reproductive Technology Embryo Grading System and Proposed Modification | 20.0 | 0 | 1 |
| Models Predicting Success of Infertility Treatment: A Systematic Review | 20.0 | 0 | 1 |
| International Patients' Travel Decision Making Process- A Conceptual Framework | 20.0 | 0 | 1 |
| The endometrium in assisted reproductive technology: How thin is thin? | 20.0 | 0 | 1 |
| Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET) | 20.0 | 0 | 1 |
| Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis | 20.0 | 0 | 1 |
| Fertility treatment in spinal cord injury and other neurologic disease | 20.0 | 0 | 1 |
| Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine | 20.0 | 0 | 1 |
| Clinical determinants of mental disorders occurring during the infertility treatment | 20.0 | 0 | 1 |
| Bibliometric mapping and clustering analysis of Iranian papers on reproductive medicine in Scopus database (2010-2014) | 20.0 | 0 | 1 |
| Blue Button use by patients to access and share health record information using the Department of Veterans Affairs' online patient portal | 20.0 | 0 | 1 |
| The “Open Letter”: Radiologists' Reports in the Era of Patient Web Portals | 20.0 | 0 | 1 |
| Patients, care partners, and shared access to the patient portal: online practices at an integrated health system | 20.0 | 0 | 1 |
| Stem cells in reproductive medicine: ready for the patient? | 20.0 | 0 | 1 |
| Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? | 20.0 | 0 | 1 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 20.0 | 0 | 1 |
| Remote monitoring as a key innovation in the management of cardiac patients including those with implantable electronic devices | 20.0 | 0 | 1 |
| The presence, role and clinical use of spermatozoal RNAs | 20.0 | 0 | 1 |
| Infertility and reproductive medicine clinics of North America | 20.0 | 0 | 1 |
| Iranian journal of reproductive medicine Yazd Research & Clinical Centre for Infertility | 20.0 | 0 | 1 |
| Clinical and experimental reproductive medicine | 20.0 | 0 | 1 |
| Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Assisted reproductive technology in India: A 3 year retrospective data analysis | 20.0 | 0 | 1 |
| Gasotransmitters in Gametogenesis and Early Development: Holy Trinity for Assisted Reproductive Technology-A Review | 20.0 | 0 | 1 |
| Assisted reproductive technology after the birth of louise brown | 20.0 | 0 | 1 |
| Assisted reproductive technology and birth defects: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Reproduction and Breast Cancer Risk | 20.0 | 0 | 1 |
| Current status of assisted reproductive technology in Korea, 2009 | 20.0 | 0 | 1 |
| The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? | 20.0 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment. Part II-Mental health and development outcomes | 20.0 | 0 | 1 |
| Insect Biometrics: Optoacoustic Signal Processing and Its Applications to Remote Monitoring of McPhail Type Traps | 20.0 | 0 | 1 |
| Remote monitoring of breathing dynamics using infrared thermography | 20.0 | 0 | 1 |
| Mary Barton | 20.0 | 0 | 1 |
| Remote monitoring of patients with implanted cardiac devices. | 20.0 | 0 | 1 |
| PGS-FISH in reproductive medicine and perspective directions for improvement: a systematic review | 20.0 | 0 | 1 |
| Journal of in vitro fertilization and embryo transfer : IVF | 20.0 | 0 | 1 |
| Seminars in reproductive endocrinology | 20.0 | 0 | 1 |
| Annual progress in reproductive medicine | 20.0 | 0 | 1 |
| International journal of reproductive medicine | 20.0 | 0 | 1 |
| International journal of gynecological obstetrical and reproductive medicine research | 20.0 | 0 | 1 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 20.0 | 0 | 1 |
| Subclinical Atrial Tachyarrhythmias:Implantable Devices and Remote Monitoring | 20.0 | 0 | 1 |
| Benefits and challenges of caring for international patients | 20.0 | 0 | 1 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 20.0 | 0 | 1 |
| Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review | 20.0 | 0 | 1 |
| Disaster and Contingency Planning for Scientific Shared Resource Cores | 20.0 | 0 | 1 |
| Methods for endometrial preparation in frozen-thawed embryo transfer cycles | 20.0 | 0 | 1 |
| Cost-effectiveness of varicocele surgery in the era of assisted reproductive technology | 20.0 | 0 | 1 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 20.0 | 0 | 1 |
| Granulocyte colony-stimulating factor and reproductive medicine: A review | 20.0 | 0 | 1 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 20.0 | 0 | 1 |
| Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine | 20.0 | 0 | 1 |
| The paternal genome and the health of the assisted reproductive technology child | 20.0 | 0 | 1 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 20.0 | 0 | 1 |
| The impact of remote patient monitoring in managing silent myocardial infarction in a residential home setting | 20.0 | 0 | 1 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 20.0 | 0 | 1 |
| John Zhang | 20.0 | 0 | 1 |
| Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate | 20.0 | 0 | 1 |
| Birth after the reimplantation of a human embryo | 20.0 | 0 | 1 |
| Effect of the mode of assisted reproductive technology conception on obstetric outcomes for survivors of the vanishing twin syndrome | 20.0 | 0 | 1 |
| Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety | 20.0 | 0 | 1 |
| Transplantation in reproductive medicine: previous experience, present knowledge and future prospects | 20.0 | 0 | 1 |
| Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure | 20.0 | 0 | 1 |
| Successful treatment of cervical stenosis with hysteroscopic canalization before embryo transfer in patients undergoing IVF: a case series | 20.0 | 0 | 1 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 20.0 | 0 | 1 |
| Comparative proteomic analysis of human placenta derived from assisted reproductive technology | 20.0 | 0 | 1 |
| Raman microspectroscopy: shining a new light on reproductive medicine | 20.0 | 0 | 1 |
| In-vitro cervical mucus-sperm penetration tests and outcome of infertility treatments in couples with repeatedly negative post-coital tests | 20.0 | 0 | 1 |
| Is a male infertility clinic of any use? | 20.0 | 0 | 1 |
| Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Personal power-frequency magnetic field exposure in women recruited at an infertility clinic: association with physical activity and temporal variability | 20.0 | 0 | 1 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Soy food intake and treatment outcomes of women undergoing assisted reproductive technology | 20.0 | 0 | 1 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Q28392006 | 20.0 | 0 | 1 |
| Urinary Paraben Concentrations and Ovarian Aging among Women from a Fertility Center | 20.0 | 0 | 1 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial | 20.0 | 0 | 1 |
| Maternal whole grain intake and outcomes of in vitro fertilization | 20.0 | 0 | 1 |
| Urinary phthalate metabolites and ovarian reserve among women seeking infertility care | 20.0 | 0 | 1 |
| Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment | 20.0 | 0 | 1 |
| PERSONAL MEASURES OF POWER-FREQUENCY MAGNETIC FIELD EXPOSURE AMONG MEN FROM AN INFERTILITY CLINIC: DISTRIBUTION, TEMPORAL VARIABILITY AND CORRELATION WITH THEIR FEMALE PARTNERS' EXPOSURE | 20.0 | 0 | 1 |
| Paternal Urinary Concentrations of Parabens and Other Phenols in Relation to Reproductive Outcomes among Couples from a Fertility Clinic | 20.0 | 0 | 1 |
| Biomarkers in reproductive medicine: the promise, and can it be fulfilled? | 20.0 | 0 | 1 |
| Ontogeny of adenosine deaminase in the mouse decidua and placenta: immunolocalization and embryo transfer studies | 20.0 | 0 | 1 |
| Effect of sperm DNA fragmentation on clinical outcome of frozen-thawed embryo transfer and on blastocyst formation | 20.0 | 0 | 1 |
| Congenital Malformations among Babies Born Following Letrozole or Clomiphene for Infertility Treatment | 20.0 | 0 | 1 |
| Zika virus and Assisted Reproductive Technology: to test or not to test, that is the question. Is it an unnecessary cost? The first two months of mandatory testing in an outbreak area in Rio de Janeiro, Brazil | 20.0 | 0 | 1 |
| A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients | 20.0 | 0 | 1 |
| Secure Authentication for Remote Patient Monitoring with Wireless Medical Sensor Networks | 20.0 | 0 | 1 |
| Three Giants in the Cradle of Reproductive Medicine; Reproduction Theories of the Seventeenth Century as Discerned by Pregnancy Portraiture in the Oeuvre of Jan Vermeer | 20.0 | 0 | 1 |
| Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials | 20.0 | 0 | 1 |
| Disparities in Enrollment and Use of an Electronic Patient Portal | 20.0 | 0 | 1 |
| Roger Gosden | 20.0 | 0 | 1 |
| The effect of intrauterine human chorionic gonadotropin injection before embryo transfer on the implantation and pregnancy rate in infertile patients: A randomized clinical trial | 20.0 | 0 | 1 |
| The effect of endometrial injury on pregnancy rate in frozen-thawed embryo transfer: A randomized control trial | 20.0 | 0 | 1 |
| Reproductive Endocrinology and Infertility | 20.0 | 0 | 1 |
| GIFT The Hope for Future Infertility Treatment | 20.0 | 0 | 1 |
| Use of granulocyte-colony stimulating factor in assisted reproductive technology: A systematic review and meta-analysis | 20.0 | 0 | 1 |
| Is a Male Infertility Clinic of Any Use? | 20.0 | 0 | 1 |
| William F. Crowley | 20.0 | 0 | 1 |
| Resource Estimations in Contingency Planning for Foot-and-Mouth Disease | 20.0 | 0 | 1 |
| Dengue Contingency Planning: From Research to Policy and Practice | 20.0 | 0 | 1 |
| The Impact of Age upon Contingency Planning for Multiple-casualty Incidents Based on a Single Center's Experience. | 20.0 | 0 | 1 |
| Contingency planning for electronic health record-based care continuity: a survey of recommended practices. | 20.0 | 0 | 1 |
| “We Don't Have a Back-Up Plan”: An Exploration of Family Contingency Planning for Emergencies Following Stroke | 20.0 | 0 | 1 |
| Contingency planning: preparation of contingency plans | 20.0 | 0 | 1 |
| Psychiatric aspects of infertility and infertility treatments | 20.0 | 0 | 1 |
| Thinking ahead about reproductive health: contingency planning and emergency preparedness in crisis situations (Iraq and West Africa). | 20.0 | 0 | 1 |
| Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 20.0 | 0 | 1 |
| Short and long term outcomes of children conceived with assisted reproductive technology | 20.0 | 0 | 1 |
| Pregnancy after oocyte donation in 45, X Turner syndrome women, complicated by gestational diabetes and polyhydramnios. Case report and mini-review of literature | 20.0 | 0 | 1 |
| Remotely engaged: Lessons from remote monitoring in multiple sclerosis | 20.0 | 0 | 1 |
| Midwest Fertility Specialists | 20.0 | 0 | 1 |
| Southeastern Fertility Center | 20.0 | 0 | 1 |
| Howard and Georgeanna Jones Foundation for Reproductive Medicine | 20.0 | 0 | 1 |
| An Asynchronous Online Collaboration Between Radiologists and Patients: Harnessing the Power of Informatics to Design the Ideal Patient Portal | 20.0 | 0 | 1 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Telemedicine and Remote Monitoring: Supporting the Patient on Peritoneal Dialysis | 20.0 | 0 | 1 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 20.0 | 0 | 1 |
| Institute for Reproductive Medicine | 20.0 | 0 | 1 |
| Reproductive Medicine Institute | 20.0 | 0 | 1 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 20.0 | 0 | 1 |
| Alternative treatments in reproductive medicine. The vexing problem of 'seemingly impeccable trials...'. | 20.0 | 0 | 1 |
| Determining access to assisted reproductive technology: reactions of clinic directors to ethically complex case scenarios | 20.0 | 0 | 1 |
| An update on embryo culture for human assisted reproductive technology: media, performance, and safety | 20.0 | 0 | 1 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 20.0 | 0 | 1 |
| Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes | 20.0 | 0 | 1 |
| Recruitment strategies in two reproductive medicine network infertility trials | 20.0 | 0 | 1 |
| homeSound: Real-Time Audio Event Detection Based on High Performance Computing for Behaviour and Surveillance Remote Monitoring. | 20.0 | 0 | 1 |
| Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Infertile couples' experience of family stress while women are hospitalized for ovarian hyperstimulation syndrome during infertility treatment | 20.0 | 0 | 1 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 20.0 | 0 | 1 |
| Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. | 20.0 | 0 | 1 |
| Distributive justice and infertility treatment in Canada | 20.0 | 0 | 1 |
| Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations | 20.0 | 0 | 1 |
| Epidemic of plurality and contributions of assisted reproductive technology therein | 20.0 | 0 | 1 |
| Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs | 20.0 | 0 | 1 |
| Genetic characteristics of the couple with non-syndromic sensorineural hearing loss and fertility guidance | 20.0 | 0 | 1 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 20.0 | 0 | 1 |
| Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology. | 20.0 | 0 | 1 |
| Prevention of prematurity by single embryo transfer | 20.0 | 0 | 1 |
| Letrozole versus clomiphene for infertility in the polycystic ovary syndrome | 20.0 | 0 | 1 |
| Regulating (or not) reproductive medicine: an alternative to letting the market decide | 20.0 | 0 | 1 |
| DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials | 20.0 | 0 | 1 |
| An assessment of the effectiveness of high definition cameras as remote monitoring tools for dolphin ecology studies | 20.0 | 0 | 1 |
| Body mass index and intercourse compliance | 20.0 | 0 | 1 |
| Altering hirsutism through ovulation induction in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Assisted reproductive technology: a dilemma for the nursing profession. | 20.0 | 0 | 1 |
| Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Inhibin, activin, and follistatin in reproductive medicine | 20.0 | 0 | 1 |
| Technological approaches to remote monitoring of elderly people in cardiology: a usability perspective. | 20.0 | 0 | 1 |
| Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism | 20.0 | 0 | 1 |
| Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial | 20.0 | 0 | 1 |
| Predictors of pregnancy in women with polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial | 20.0 | 0 | 1 |
| Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene | 20.0 | 0 | 1 |
| Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome | 20.0 | 0 | 1 |
| Remote monitoring for the wearable artificial kidney | 20.0 | 0 | 1 |
| Remote monitoring for continuous peritoneal dialysis | 20.0 | 0 | 1 |
| Use of a Real-Time Remote Monitoring Network (RTRM) to Characterize the Guadalquivir Estuary (Spain) | 20.0 | 0 | 1 |
| Use of remote monitoring in the management of system-related complications in implantable defibrillator patients | 20.0 | 0 | 1 |
| Remote monitoring in implantable defibrillator therapy | 20.0 | 0 | 1 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 20.0 | 0 | 1 |
| Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer | 20.0 | 0 | 1 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 20.0 | 0 | 1 |
| Potential role of telemedical service centers in managing remote monitoring data transmitted daily by cardiac implantable electronic devices: results of the early detection of cardiovascular events in device patients with heart failure (detecT-Pilot | 20.0 | 0 | 1 |
| Wearable wireless wonder. Remote monitoring transmits data for patient assessment in the field | 20.0 | 0 | 1 |
| Cultivation of the notochord of a Balanoglossus species in diffusion chambers | 20.0 | 0 | 1 |
| States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. | 20.0 | 0 | 1 |
| Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set | 20.0 | 0 | 1 |
| Remote monitoring of implantable pacemakers: in-office setup significantly improves successful data transmission | 20.0 | 0 | 1 |
| Medical genetics in reproductive medicine | 20.0 | 0 | 1 |
| Efficacy, safety, and trends in assisted reproductive technology in Japan-analysis of four-year data from the national registry system | 20.0 | 0 | 1 |
| Health and Development of Children Born after Assisted Reproductive Technology and Sub-Fertility Compared to Naturally Conceived Children: Data from a National Study | 20.0 | 0 | 1 |
| The merits of blastocyst versus cleavage stage embryo transfer: a Cochrane review | 20.0 | 0 | 1 |
| Manpower and outpatient clinic workload for remote monitoring of patients with cardiac implantable electronic devices: data from the HomeGuide Registry. | 20.0 | 0 | 1 |
| Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews | 20.0 | 0 | 1 |
| Births resulting from assisted reproductive technology: comparing birth certificate and National ART Surveillance System Data, 2011 | 20.0 | 0 | 1 |
| Global satellite monitoring of climate-induced vegetation disturbances. | 20.0 | 0 | 1 |
| The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study | 20.0 | 0 | 1 |
| Use of assisted reproductive technology treatment as reported by mothers in comparison with registry data: the Upstate KIDS Study. | 20.0 | 0 | 1 |
| Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database | 20.0 | 0 | 1 |
| Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan | 20.0 | 0 | 1 |
| Exercise ASKARI SERPENT: enabling clinical data collection during exercises and operations to support future contingency planning and assurance of category-based reporting systems | 20.0 | 0 | 1 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 20.0 | 0 | 1 |
| Pulse averaging methods for a laser remote monitoring system using atmospheric backscatter | 20.0 | 0 | 1 |
| Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. | 20.0 | 0 | 1 |
| Birth defects after assisted reproductive technology according to the method of treatment in Japan: nationwide data between 2004 and 2012 | 20.0 | 0 | 1 |
| Risk of birth defects among children conceived with assisted reproductive technology: providing an epidemiologic context to the data | 20.0 | 0 | 1 |
| Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012 | 20.0 | 0 | 1 |
| Linking birth and infant death records with assisted reproductive technology data: Massachusetts, 1997-1998. | 20.0 | 0 | 1 |
| Register data on Assisted Reproductive Technology (ART) in Europe including a detailed description of ART in Denmark | 20.0 | 0 | 1 |
| Accuracy of self-reported survey data on assisted reproductive technology treatment parameters and reproductive history. | 20.0 | 0 | 1 |
| Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012 | 20.0 | 0 | 1 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 20.0 | 0 | 1 |
| Design considerations and implementation of a cost-effective, portable remote monitoring unit using 3G wireless data networks | 20.0 | 0 | 1 |
| The German Middleway as Precursor for Single Embryo Transfer. A Retrospective Data-analysis of the Düsseldorf University Hospital's Interdisciplinary Fertility Centre - UniKiD. | 20.0 | 0 | 1 |
| Use of remote monitoring in the management of ICD end-of-life: Data from the DECODE registry | 20.0 | 0 | 1 |
| Evaluation of remote monitoring of parturition in dairy cattle as a new tool for calving management | 20.0 | 0 | 1 |
| Assisted reproductive technology: official data on the application of the Italian law. | 20.0 | 0 | 1 |
| Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients | 20.0 | 0 | 1 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 20.0 | 0 | 1 |
| Efficacy of nafarelin in assisted reproductive technology: a meta-analysis | 20.0 | 0 | 1 |
| Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows | 20.0 | 0 | 1 |
| A two- versus three-embryo transfer: the oocyte donation model | 20.0 | 0 | 1 |
| Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone | 20.0 | 0 | 1 |
| Paging the worldwide cardiology consultant: the Army Knowledge Online Telemedicine Consultation Program in cardiology | 20.0 | 0 | 1 |
| Limitations of the past and latest evolutions of home monitoring: arrhythmia electrograms transmitted automatically improve the efficacy of remote monitoring | 20.0 | 0 | 1 |
| Long-term patient acceptance of and satisfaction with implanted device remote monitoring | 20.0 | 0 | 1 |
| Effectiveness of remote monitoring in the management of syncope and palpitations | 20.0 | 0 | 1 |
| Remote monitoring of a high-risk patient with Brugada syndrome: association of different arrhythmic manifestations | 20.0 | 0 | 1 |
| Effectiveness and Safety of Remote Monitoring of Patients With an Implantable Loop Recorder | 20.0 | 0 | 1 |
| Holter ECG for pacemaker/defibrillator carriers: what is its role in the era of remote monitoring? | 20.0 | 0 | 1 |
| Proteomics in reproductive medicine: the technology for separation and identification of proteins | 20.0 | 0 | 1 |
| A randomized double-blind controlled study of the efficacy of laser-assisted hatching on implantation and pregnancy rates of frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 20.0 | 0 | 1 |
| Present state of reproductive medicine in Japan - ethical issues with a focus on those seen in court cases | 20.0 | 0 | 1 |
| Applications of microarray in reproductive medicine. | 20.0 | 0 | 1 |
| A list and analysis of reproductive medicine periodicals indexed in MEDLINE in 2006 | 20.0 | 0 | 1 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 20.0 | 0 | 1 |
| Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy | 20.0 | 0 | 1 |
| The Development of a Remote Patient Monitoring System using Java-enabled Mobile Phones | 20.0 | 0 | 1 |
| Effect of passive uterine straightening during embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Assisted Reproductive Technology affects developmental kinetics, H19 Imprinting Control Region methylation and H19 gene expression in individual mouse embryos | 20.0 | 0 | 1 |
| A remote patient monitoring system using a Java-enabled 3G mobile phone | 20.0 | 0 | 1 |
| Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Errors in spectroscopic measurements of SO2 due to nonexponential absorption of laser radiation, with application to the remote monitoring of atmospheric pollutants | 20.0 | 0 | 1 |
| Absorption coefficients of chlorine-dioxide at 12C16O2 and 12C18O2 laser wavelengths:applications to remote monitoring in the working environment | 20.0 | 0 | 1 |
| Laser photoacoustic spectrometer for remote monitoring of atmospheric pollutants | 20.0 | 0 | 1 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 20.0 | 0 | 1 |
| Effect of the size of zona pellucida opening by laser assisted hatching on clinical outcome of frozen cleaved embryos that were cultured to blastocyst after thawing in women with multiple implantation failures of embryo transfer: a retrospective stu | 20.0 | 0 | 1 |
| Impact of assisted hatching on fresh and frozen-thawed embryo transfer cycles: a prospective, randomized study | 20.0 | 0 | 1 |
| I see you. As focus sharpens on the intensive care unit, remote monitoring capabilities and integration issues are under the microscope. | 20.0 | 0 | 1 |
| Outpatient hysteroscopy and subsequent IVF cycle outcome: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Indications and options for endometrial ablation | 20.0 | 0 | 1 |
| Controversies in clinical embryology: embryo selection towards single embryo transfer - 16 July 2008, University of Manchester | 20.0 | 0 | 1 |
| Effect of stem cell activation, culture media of manipulated embryos, and site of embryo transfer in the production of F0 embryonic stem cell mice. | 20.0 | 0 | 1 |
| Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine | 20.0 | 0 | 1 |
| Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies | 20.0 | 0 | 1 |
| Remote Monitoring Technologies for the Prevention of Metabolic Syndrome: The Diabetes and Technology for Increased Activity (DaTA) Study | 20.0 | 0 | 1 |
| A usability study of patients setting up a cardiac event loop recorder and BlackBerry gateway for remote monitoring at home | 20.0 | 0 | 1 |
| Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease | 20.0 | 0 | 1 |
| Design of the remote monitoring system of vital sign based on smartphone and mobile internet | 20.0 | 0 | 1 |
| Mobile health in cardiology: a review of currently available medical apps and equipment for remote monitoring | 20.0 | 0 | 1 |
| Remote monitoring of blood pressure to reduce the risk of preeclampsia related complications with an innovative use of mobile technology | 20.0 | 0 | 1 |
| The bioethics law revision: comparative analysis of contributions from different public and professional offices. Assisted Reproductive Technology, embryo and stem cells research, umbilical cord blood bank | 20.0 | 0 | 1 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 20.0 | 0 | 1 |
| Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS. | 20.0 | 0 | 1 |
| Incorporating natural variation into IVF clinic league tables: The Expected Rank | 20.0 | 0 | 1 |
| Significance of reproductive medicine in regard to judicial and ethical concerns in Germany | 20.0 | 0 | 1 |
| Legitimate data in remote monitoring | 20.0 | 0 | 1 |
| Embryo recovery rate and recipients' pregnancy rate after nonsurgical embryo transfer in donkeys | 20.0 | 0 | 1 |
| Effect of laser zona thinning on vitrified-warmed embryo transfer at the cleavage stage: a prospective, randomized study | 20.0 | 0 | 1 |
| Embryo transfer in rabbits | 20.0 | 0 | 1 |
| Contingency planning for a deliberate release of smallpox in Great Britain--the role of geographical scale and contact structure | 20.0 | 0 | 1 |
| Reproductive endocrinology: quo vadis? Scientific, social, ethical and economic challenges. | 20.0 | 0 | 1 |
| Preparation of endometrium for egg donation | 20.0 | 0 | 1 |
| Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Dairy intake and semen quality among men attending a fertility clinic | 20.0 | 0 | 1 |
| Patient Portals as a Tool for Health Care Engagement: A Mixed-Method Study of Older Adults With Varying Levels of Health Literacy and Prior Patient Portal Use | 20.0 | 0 | 1 |
| Results from adding recombinant LH for assisted reproductive technology treatment: A randomized control trial | 20.0 | 0 | 1 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 20.0 | 0 | 1 |
| Harlequin ichthyosis in a neonate born with assisted reproductive technology: a case report | 20.0 | 0 | 1 |
| A systematic review of clinician and staff views on the acceptability of incorporating remote monitoring technology into primary care | 20.0 | 0 | 1 |
| Institutional review boards (IRBs) and reproductive medicine: guidelines for compliance | 20.0 | 0 | 1 |
| Psychological Disorders among Iranian Infertile Couples Undergoing Assisted Reproductive Technology (ART). | 20.0 | 0 | 1 |
| The status of assisted reproductive technology in Korea in 2012 | 20.0 | 0 | 1 |
| Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities | 20.0 | 0 | 1 |
| The State of Reproductive Medicine in Germany | 20.0 | 0 | 1 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 20.0 | 0 | 1 |
| Assessment of endometrial and ovarian characteristics using three dimensional power Doppler ultrasound to predict response in frozen embryo transfer cycles | 20.0 | 0 | 1 |
| Elective single embryo transfer following in vitro fertilization | 20.0 | 0 | 1 |
| Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. | 20.0 | 0 | 1 |
| Abrupt disruption of remote monitoring transmission as an indicator of safe backup mode | 20.0 | 0 | 1 |
| Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic | 20.0 | 0 | 1 |
| Retrospective clinical analysis of two artificial shrinkage methods applied prior to blastocyst vitrification on the outcome of frozen embryo transfer | 20.0 | 0 | 1 |
| Serum progesterone concentration on day of embryo transfer in donor oocyte cycles | 20.0 | 0 | 1 |
| Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT | 20.0 | 0 | 1 |
| The Internet, intranets and reproductive medicine | 20.0 | 0 | 1 |
| What factors are important for successful embryo transfer after in-vitro fertilization? | 20.0 | 0 | 1 |
| Assisted reproductive technology. | 20.0 | 0 | 1 |
| The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial | 20.0 | 0 | 1 |
| Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical tri | 20.0 | 0 | 1 |
| Attitudes of Infertile Couples, Fertility Clinic Staff and Researchers toward Personhood of The Human Embryo in Iran | 20.0 | 0 | 1 |
| Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates | 20.0 | 0 | 1 |
| Is a Blanket Elective Single Embryo Transfer Policy Defensible? | 20.0 | 0 | 1 |
| Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations | 20.0 | 0 | 1 |
| Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States | 20.0 | 0 | 1 |
| Recombinant follitropin alfa/lutropin alfa in fertility treatment. | 20.0 | 0 | 1 |
| Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives. | 20.0 | 0 | 1 |
| Methods of using real-time social media technologies for detection and remote monitoring of HIV outcomes | 20.0 | 0 | 1 |
| Promoting the use of elective single embryo transfer in clinical practice | 20.0 | 0 | 1 |
| Heterologous Embryo Transfer: Magisterial Answers and Metaphysical Questions | 20.0 | 0 | 1 |
| Enhancing pregnant, donor oocyte recipient women's health in the infertility clinic and beyond: a phenomenological investigation of caring behaviour | 20.0 | 0 | 1 |
| Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. | 20.0 | 0 | 1 |
| Effective technologies for noninvasive remote monitoring in heart failure | 20.0 | 0 | 1 |
| The efficacy and adverse effects of in vitro fertilization and embryo transfer | 20.0 | 0 | 1 |
| Use of fertility treatment modalities in a large United States cohort of professional women. | 20.0 | 0 | 1 |
| Embryo transfer cannot delineate between the maternal pregnancy environment and germ line effects in the transgenerational transmission of disease in rats | 20.0 | 0 | 1 |
| The role of ovarian volume in reproductive medicine. | 20.0 | 0 | 1 |
| Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: case report | 20.0 | 0 | 1 |
| A greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles | 20.0 | 0 | 1 |
| Long term costs and effects of reducing the number of twin pregnancies in IVF by single embryo transfer: the TwinSing study | 20.0 | 0 | 1 |
| Reproductive endocrinology of female elasmobranchs: lessons from the little skate (Raja erinacea) and spiny dogfish (Squalus acanthias). | 20.0 | 0 | 1 |
| Laparoscopy vs. laparotomy for embryo transfer to produce transgenic goats (Capra hircus). | 20.0 | 0 | 1 |
| Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment | 20.0 | 0 | 1 |
| We need a prospective varicocelectomy trial | 20.0 | 0 | 1 |
| Frozen embryo transfer prevents the detrimental effect of high estrogen on endometrium receptivity | 20.0 | 0 | 1 |
| GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles | 20.0 | 0 | 1 |
| Success of frozen embryo transfer: Does the type of gonadotropin influence the outcome? | 20.0 | 0 | 1 |
| Perspectives of older people about contingency planning for falls in the community: A qualitative meta-synthesis | 20.0 | 0 | 1 |
| Factors associated with the use of elective single-embryo transfer and pregnancy outcomes in the United States, 2004-2012. | 20.0 | 0 | 1 |
| Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis. | 20.0 | 0 | 1 |
| Attitudes and interest in technology-based treatment and the remote monitoring of smoking among adolescents and emerging adults | 20.0 | 0 | 1 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 20.0 | 0 | 1 |
| Increase in Cancer Center Staff Effort Related to Electronic Patient Portal Use. | 20.0 | 0 | 1 |
| Current status of comprehensive chromosome screening for elective single-embryo transfer. | 20.0 | 0 | 1 |
| Medical applications of shortwave FM radar: remote monitoring of cardiac and respiratory motion | 20.0 | 0 | 1 |
| Compliance with vessel speed restrictions to protect North Atlantic right whales | 20.0 | 0 | 1 |
| "Interactive technology assessment" and beyond: the field trial of genetically modified grapevines at INRA-Colmar | 20.0 | 0 | 1 |
| Desire for a child and eating disorders in women seeking infertility treatment | 20.0 | 0 | 1 |
| GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis | 20.0 | 0 | 1 |
| Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study | 20.0 | 0 | 1 |
| Association between assisted reproductive technology and advanced retinopathy of prematurity | 20.0 | 0 | 1 |
| The past, present and future of reproductive endocrinology. | 20.0 | 0 | 1 |
| Tubal surgery in the era of assisted reproductive technology: clinical options | 20.0 | 0 | 1 |
| Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA. | 20.0 | 0 | 1 |
| Ocular Manifestations in Infants Resulted from Assisted Reproductive Technology (ART) | 20.0 | 0 | 1 |
| CGM, Pregnancy, and Remote Monitoring | 20.0 | 0 | 1 |
| Potential liability of reproductive endocrinologists for high order multiple gestation. | 20.0 | 0 | 1 |
| Calculating length of gestation from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) database versus vital records may alter reported rates of prematurity | 20.0 | 0 | 1 |
| Genetic-based and assisted reproductive technology of the 21st century. | 20.0 | 0 | 1 |
| Fertility treatment in HIV needs multidisciplinary team | 20.0 | 0 | 1 |
| Outcome of assisted reproductive technology in overweight and obese women | 20.0 | 0 | 1 |
| Treatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin | 20.0 | 0 | 1 |
| Number of embryos allowed in fertility treatment should be flexible | 20.0 | 0 | 1 |
| Cyclooxygenases in reproductive medicine and biology | 20.0 | 0 | 1 |
| Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes | 20.0 | 0 | 1 |
| Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic | 20.0 | 0 | 1 |
| Ethical Issues Currently Being Discussed in Relation to Reproductive Medicine and the Laws Governing Reproductive Medicine | 20.0 | 0 | 1 |
| Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication | 20.0 | 0 | 1 |
| LH-RH analogues: I. Their impact on reproductive medicine | 20.0 | 0 | 1 |
| Comprehensive assessment of serum estradiol impact on selected physiologic markers observed during in-vitro fertilization and embryo transfer cycles. | 20.0 | 0 | 1 |